Indian pharma Cadila Healthcare has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial.

Indian pharma Cadila seeks approval to repurpose Hepatitis C drug for COVID-19

hepatitis-c-drug

Hepatitis C Drug, News on Hepatitis C Drug, stories on Hepatitis C Drug, articles on Hepatitis C Drug, Hepatitis C Drug stories at Wion, Hepatitis C Drug news, Hepatitis C Drug latest news

hepatitis c-drug

Indian pharma Cadila seeks approval to repurpose Hepatitis C drug for COVID-19